Schematic of thermally triggered theranostic nanoparticle methods in vivo. iTSLs are injected i.v. and allowed to accumulate in the tumour due to the EPR effect, while monitoring by imaging. Once the concentration is thought optimal, the therapeutic agent is locally released with hyperthermia. Exposure of the cancer cells to a high local concentration of agent within a short period of time maximises cytotoxicity.